Nisa Investment Advisors
VBIV

Nisa Investment Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Nisa Investment Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$132 – 2858
2023
Q2 		$132 Buy
40
+23
+135% +$70 ﹤0.01% 2750
2023
Q1 		$0 Hold
17
– – ﹤0.01% 2761
2022
Q4 		$0 Buy
+17
New +$300 ﹤0.01% 2765
2022
Q2 		– Sell
-4,227
Closed -$210K – 2533
2022
Q1 		$210K Buy
4,227
+3,875
+1,101% +$191K ﹤0.01% 1359
2021
Q4 		$18K Sell
352
-3,348
-90% -$282K ﹤0.01% 1942
2021
Q3 		$345 Hold
3,700
– – ﹤0.01% 1233
2021
Q2 		$372 Hold
3,700
– – ﹤0.01% 1214
2021
Q1 		$345 Hold
3,700
– – ﹤0.01% 1286
2020
Q4 		$305K Buy
+3,700
New +$316K ﹤0.01% 1320

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nisa Investment Advisors's VBIV Position: Q3 2023 in Review

Nisa Investment Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 40 shares — an estimated $132 sold.

Nisa Investment Advisors first reported a position in VBIV in Q4 2020 and held it in 9 quarters. The position peaked at $305K in Q4 2020. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

  • Nisa Investment Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 40 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $132.
  • Nisa Investment Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 9 quarters.
  • Nisa Investment Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $305K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.